BoB@JPM: Self-Replicating RNA With Elixirgen's Akihiro Ko

We love to hear from our listeners. Send us a message. SPECIAL EDITION: BoB@JPMElixirgen Therapeutics CEO Akihiro Ko joins the Business of Biotech for the final episode in our special series recorded at JPM Week in San Francico. Life Science Leader Chief Editor Ben Comer joined us for the conversation. We dive deep into Elixirgen's unique, temperature-controlled in-vivo gene expression technology designed to address common cell therapy administration challenges and unwanted, off-target ...